Atıf Formatları
Punicic acid inhibits glioblastoma migration and proliferation via the PI3K/AKT1/mTOR signaling pathway
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

M. METE Et Al. , "Punicic acid inhibits glioblastoma migration and proliferation via the PI3K/AKT1/mTOR signaling pathway," Anti-Cancer Agents in Medicinal Chemistry , vol.19, no.9, pp.1120-1131, 2019

METE, M. Et Al. 2019. Punicic acid inhibits glioblastoma migration and proliferation via the PI3K/AKT1/mTOR signaling pathway. Anti-Cancer Agents in Medicinal Chemistry , vol.19, no.9 , 1120-1131.

METE, M., Unsal, U. U., Aydemir, I., Sönmez, P. K., & TUĞLU, M. İ., (2019). Punicic acid inhibits glioblastoma migration and proliferation via the PI3K/AKT1/mTOR signaling pathway. Anti-Cancer Agents in Medicinal Chemistry , vol.19, no.9, 1120-1131.

METE, MESUT Et Al. "Punicic acid inhibits glioblastoma migration and proliferation via the PI3K/AKT1/mTOR signaling pathway," Anti-Cancer Agents in Medicinal Chemistry , vol.19, no.9, 1120-1131, 2019

METE, MESUT Et Al. "Punicic acid inhibits glioblastoma migration and proliferation via the PI3K/AKT1/mTOR signaling pathway." Anti-Cancer Agents in Medicinal Chemistry , vol.19, no.9, pp.1120-1131, 2019

METE, M. Et Al. (2019) . "Punicic acid inhibits glioblastoma migration and proliferation via the PI3K/AKT1/mTOR signaling pathway." Anti-Cancer Agents in Medicinal Chemistry , vol.19, no.9, pp.1120-1131.

@article{article, author={MESUT METE Et Al. }, title={Punicic acid inhibits glioblastoma migration and proliferation via the PI3K/AKT1/mTOR signaling pathway}, journal={Anti-Cancer Agents in Medicinal Chemistry}, year=2019, pages={1120-1131} }